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Abstract
Background: Hypercholesterolemia is a condition characterised with high level of cholesterol in the blood.
Objectives: The effect of ethanolic extract of Buchholzia coriacea (EEBC) on the lipid profile levels and extent of lipid
peroxidation in hypercholesterolemic albino rats was investigated in this study.
Methods: Thirty albino rats were divided into six different groups which consist of group 1 (control), group 2
(hypercholesterolemic rats), group 3 (hypercholesterolemic rats treated with ethanolic extract of EEBC), group 4
(hypercholesterolemic rats treated with questran), group 5 (normal rats treated with EEBC) and group 6 (normal rats treated
with questran). The rats were sacrificed at the end of  the sixth week and assay conducted for Aspartate Transaminase (AST),
Alanine Transaminase (ALT), lipid profile and biomarker of  oxidative stress.
Results: The serum and liver total cholesterol and LDL – cholesterol levels as well as lipid peroxidation in the EEBC–
treated hypercholesterolemic rats were significantly reduced (p < 0.05) when compared with the untreated hypercholesterolemic
rats. The activities of  AST and ALT in EEBC – treated hypercholesterolemic rats were not significantly different (p > 0.05)
from the control.
Conclusions: The results suggest that Buchholzia coriacea seeds contain potent antihypercholesterolemic agent which may
find clinical application in ameliorating hypercholesterolemia and its attendant complications.
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Hypercholesterolemia is a condition characterized
with high level of  cholesterol in the blood of  animals.
It is caused by a variety of factors which can either
be environmental or genetic.1 It is a major risk factor
in disease conditions like atherosclerosis, hypertension
and other cardiovascular diseases.2 Epidemiological
and metabolic studies have shown that serum
cholesterol levels are strongly influenced by the
amount and type of dietary fatty acids as well as the
daily intake of cholesterol both of which are dietary
factors.3 Herbal medicine, which is the use of  plants
for therapeutic or medicinal purpose has been
practiced by all cultures throughout history.4 This
practice is becoming common in Africa because it is
relatively cheap, affordable and claimed to be
effective. One of such herbal (plants) remedies is
Buchholzia coriacea (Capparaceae, common name –
magic/wonderful kola, English name – musk tree).
Different parts of the plant are traditionally used
for myriads of  therapeutic purposes. The sap exudes
with a violently spicy pungent smell that causes
sneezing.5 It is therefore turned into a pulp for
inhalation or into snuff to relieve head ache,
bronchitis, sinusitis, otitis and nasal congestion in Ivory
Coast. It is used in the treatment of small pox and
skin itch in Gabon and ear-ache in Ghana.6 Topical
application of the leaves and fruits on the body is
used to relieve fever in Sierra Leone while the seeds
are applied over the stomach to manage difficulty in
child birth.7 In Nigeria, the Edos boil and eat the
fruit after storage for a few days.8 The seed decoction
is usually made in lime or local gin for the treatment
of diabetes mellitus, hypertension, cold by traditional
healers. Its hypoglycemic activity,8 phytochemical
analysis, proximate composition and antimicrobial
studies9, 10 anthelmintic properties,11 cytotoxicity
evaluation,12 antiplasmodial activity,10 antibacterial
activity13 of various parts of the plants have been
reported. Its phytochemical screening revealed that
the seeds contain alkaloids, stem barks contain lupeol,
flavonoid, terpenes and steroids.11 This study was
designed to investigate the effects of the ethanolic
extract of  Buchholzia coriacea (EEBC) on the lipid
profile, liver activity and the degree of lipid
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peroxidation in the serum and tissues of  normal and
hypercholesterolemic wistar albino rats.
Methods
Plant Material
Fresh seeds of  Buchholzia coriacea were purchased at
Bodija market in Ibadan, Oyo State, Nigeria.
Confirmatory identification of  the plant seeds was
done at the herbarium of Botany Department,
University of Ibadan where voucher specimen was
deposited. The seeds were immediately rinsed of
debris, peeled, chopped and shade – dried for 1
week in laboratory trays. The dried seeds were
powdered and weighed. Four kilograms of  the
powdered seeds were macerated in ethanol (80%
v/v) for 48 hours with intermittent shaking. The
extracts were filtered and concentrated using a rotary
evaporator and then stored in a refrigerator for
subsequent use.
Experimental design
Thirty male albino rats weighing between 75 – 175
g were used for this investigation. They were obtained
from the Central Animal House of the Institute of
Advanced Medical Research and Training (IMRAT),
University College Hospital, Ibadan, Nigeria. They
were acclimatized for 2 weeks on normal diet of
pellitized mouse chow, with water given ad libitum at
room temperature with a 12-h light and dark cycle
before the commencement of the experiment. They
were divided into six groups, each consisting of five
animals.
Group 1 = corn oil only 0.3 ml (control)
Group 2 = questran (cholestyramine) (260 mg/
kg body weight)
Group 3 = cholesterol only (40 mg/kg body
weight)
Group 4 = cholesterol + questran
(cholestyramine) (260 mg/kg body weight)
Group 5 = cholesterol + ethanolic extract of
Buchholzia coriacea (EEBC) (250 mg/kg body
weight)
Group 6 = ethanolic extract of  Buchholzia coriacea
(EEBC) (250 mg/kg body weight)
Corn oil served as the vehicle for EEBC, questran
(cholestyramine) and cholesterol. EEBC was
dissolved in 1 ml of dimethyl sulphoxide (DMSO).
Cholestyramine, EEBC and cholesterol were
administered five times a week for six consecutive
weeks. The dose of  cholestyramine, cholesterol and
the period of treatment were selected on the basis
of  previous studies by Okoro,14  while that of  EEBC
was from Adisa et al. 8
. 
 At the end of the sixth
week, the rats were fasted overnight and sacrificed.
Biochemical assays
The serum levels of  ALT, AST were assayed by the
method of  Reitman and Frankel.15 Triglyceride was
measured by colorimetric method as described by
Fossati and Prencipe,16 total cholesterol levels were
measured  by a method of enzyme hydrolysis as
described by Richmond,17 and Roschlau et. al.18 HDL
– cholesterol was determined in both the serum and
post mitochondrial fraction (supernatant) by the
method of Jacobs et. al,19 and LDL – cholesterol
level was determined by the method of  Friedewald
et. al.20
Protein estimation
Serum total protein was estimated
spectrophotometrically according to the method
described by Gornal et al,21 with slight modifications,
using bovine serum albumin as standard.
Assay for biomarker of oxidative stress
Serum lipid peroxidation was determined
spectrophotometrically by the thiobabituric acid
reactive substances (TBARS) method as described
by Varshney and Kale,22 and was expressed in terms
of  TBARS formed per mg protein.
Stastistical analysis
The results are presented as mean ± SD of five
animals per group and statistical levels of significance
were determined using the one – way ANOVA
followed by the post hoc Duncan multiple range
tests for analysis using Statistica package, version 7.1,
Statsoft Inc. (p < 0.05 was considered significant).
Results
Table 1 shows the effects of  EEBC, questran, on
body weights and the relative weight of visceral
organs in normal and hypercholesterolemic rats.
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Table 1: Effects of  EEBC, questran, on body weights and the relative weight of  visceral organs of
















Relative organ weight = organ
weght/ body weight (%)
Kidney Liver Heart
Control 75±0.0 175±10.31 100±18.76a 0.59±0.39 5.53±0.08 0.60±0.80a 0.34±0.14 3.16±0.08 0.34±0.01
Qu* 150±0.0 195±7.56 45±10.81 0.74±0.18 6.50±1.13 0.62±0.14 0.38±0.04 3.33±0.20 0.32±0.04
Ch* 125±0.0 348±18.75 223±7.81ab 0.82±0.07b 6.72±0.08 0.96±0.06ab 0.33±0.02 2.71±0.19 0.39±0.39
Ch + Qu* 175±0.0 215±9.81 40±3.41ab 0.06±0.08 5.22±0.58 0.65±0.09 0.28±0.02 2.43±0.19 0.30±0.02
Ch+
EEBC*
150±0.0 185±1.52 35±17.01b 0.59±0.12b 5.85±0.96 0.58±0.10b 0.32±0.03 3.16±0.20 0.31±0.05
EEBC* 100±0.0 120±0.93 20±6.02 0.50±0.07 3.89±0.67 0.48±0.20 0.42±0.05 3.24±0.22 0.40±0.1
Values are mean ± SD of  five rats in each group; means with the same letters are significantly different (p < 0.05) from the
other * Qu = questran; Ch = cholesterol; EEBC = ethanolic extract of Buchholzia coriacea (EEBC)
Although cholesterol caused a significant increase in
the body weight gain of hypercholesterolemic rats
compared with the control, administration of EEBC
to hypercholesterolemic rats caused a 91.0%
significant reduction (p < 0.05) in their body weight
gain when compared with the untreated
hypercholesterolemic rats.
There was no significant difference (p > 0.05) in the
relative organ weight of the organs of all groups
except for a significant reduction (p < 0.05) in the
relative liver weight of hypercholesterolemic rats
compared with the control.
Biochemical parameters
Figures 1, 2, 3 and 4 show the effect of EEBC,
Questran in the serum, liver and kidney of  the normal
and hypercholesterolemic rats.
The concentration of total cholesterol, triglyceride,
HDL – cholesterol and LDL – cholesterol in the
serum and liver of the hypercholesterolemic rats
which were significantly increased (p < 0.05) when
compared with the control. The serum and liver total
cholesterol concentrations of the EEBC treated –
hypercholesterolemic rats were significantly reduced
(p < 0.05) by 45.9% and 44.2% respectively, when
compared with the untreated hypercholesterolemic
rats. The liver and serum LDL – cholesterol
concentration of EEBC treated –
hypercholesterolemic rats were significantly reduced
(p < 0.05) by 14.8% and 73.5% respectively, in
comparison with the untreated hypercholesterolemic
rats. The triglyceride concentration in the liver and
serum of hypercholesterolemic rats treated with
EEBC were significantly reduced by 74.6% and
48.4% respectively when compared with the
untreated hypercholesterolemic rats but there was a
significant increase (p < 0.05) in kidney triglyceride
concentration of the hypercholesterolemic rats
treated with EEBC when compared with the
hypercholesterolemic rats. Significant increases (p <
0.05) were noticed in the liver and kidney HDL –
cholesterol of hypercholesterolemic rats treated with
EEBC when compared with the untreated
hypercholesterolemic rats but the serum HDL –
cholesterol in the hypercholesterolemic rats treated
with EEBC was significantly reduced when
compared with untreated hypercholesterolemic rats.
Similar results were seen in the lipid profile levels of
hypercholesterolemic rats treated with questran when
compared with untreated hypercholesterolemic rats
as that of hypercholesterolemic treated with EEBC
except that significant decrease in the serum, liver
and kidney HDL – cholesterol were seen in the
hypercholesterolemic rats treated with questran.
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Figure 2: Effects of  EEBC, questran, on the serum, liver and kidney triglyceride levels of  the normal and
hypercholesterolemic rats
Figure 1: Effects of  EEBC, questran, on the serum, liver and kidney total cholesterol levels of  the normal and
hypercholesterolemic rats
Figure 3: Effects of  EEBC, questran, on the serum, liver and kidney HDL – cholesterol levels of  the normal and
hypercholesterolemic rats
African Health Sciences Vol 13  Issue 4 December  20131088
Biomarker of oxidative stress and liver damage
Table 2 shows the effects of  EEBC, questran, on
degree of  lipid peroxidation, AST and ALT levels
in normal and hypercholesterolemic rats
The extent of lipid peroxidation in the serum and
liver of hypercholesterolemic rats when compared
with control was significantly increased (p < 0.05)
by 18.0% and 50.9% respectively. This was
significantly reduced (p < 0.05) by 28.2% and 30.2%
in hypercholesterolemic rats treated with EEBC
respectively. There was a similar reduction in
hypercholesterolemic rats treated with questran. It
Figure 4: Effects of  EEBC, questran, on the serum, liver and kidney LDL – cholesterol levels of  the normal and
hypercholesterolemic rats
was observed that lipid peroxidation in the
hypercholesterlemic rats treated with EEBC and
those treated with questran were not significantly
different (p > 0.05) from the control.
The activities of  AST and ALT in the serum
of hypercholesterolemic rats were not significantly
different (p > 0.05) when compared with that of
normal rats. Also the activities of  AST and ALT in
the serum of EEBC – treated hypercholesterolemic
rats were not significantly different (p > 0.05) from
the normal and hypercholesterolemic rats.
Table 2: Effects of  EEBC on biomarker of  oxidative stress and liver damage*









Serum 4.1±0.3a 3.5±2.0a 5.0±0.2ab 3.9±0.3b 3.9±0.1b 4.1±0.2








Serum 12.4±3.6a 10.2±2.9 9.0±3.6 5.0±1.6 5.6±1.8a 11.2±2.8
*Values are mean±SD of  five rats in each group; mean values with superscripts a and b are significantly
different (p < 0.05) from the control and hypercholesterolemia (cholesterol-fed rats) respectively per parameter.
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Discussion
The process of atherogenesis has been considered
by many to be as a result of the acccumulation of
lipids within the artery wall. High plasma
concentrations of cholesterol (LDL – cholesterol in
particular) are one of the risk factors for
atherosclerosis and cardiovascular diseases.23
Medicinal plants are gradually gaining wide
acceptability worldwide because they are potential
sources of bioactive agents used as
pharmaceuticals.24 The ethanolic extract of  Buchholzia
coriacea has been shown  to reduce fasting blood sugar
(FBS) in streptozotocin – induced diabetic rats and
mice.8 The present study investigated the
antihypercholesterolemic effects of ethanolic extract
of  Buchholzia coriacea in cholesterol – induced
hypercholesterolemic rats.
The weight gained observed in the
hypercholesterolemic rats might be as a result of the
high rate of lipid deposit on the adipose tissue of
the rats. This might further be confirmed by the
insignificant changes observed in the relative organ
weight of the hypercholesterolemic rats when
compared with the control. The increase in the total
– cholesterol, triglycerides and LDL – cholesterol
concentration in the serum of hypercholesterolemic
rats is in agreement with a previous report, 25
confirming that serum cholesterol levels are strongly
influenced by the amount and type of dietary fatty
acid as well as the daily cholesterol intake.3 The
significant decrease observed in the serum and liver
total cholesterol in the EEBC – treated and questran
– treated hypercholesterolemic rats may be due to
the competitive inhibition of the absorption of
dietary cholesterol in the intestine of the animal or
through the stimulation of biliary excretion of bile
acid or cholesterol in faeces.26 LDL – cholesterol
which has been reported to be the major transporter
of cholesterol and also encourage the deposit of
cholesterol in the arteries27 was significantly lowered
in the hypercholesterolemic rats treated with EEBC
and questran. Clinical studies have shown that
decreasing plasma LDL – cholesterol significantly
reduces coronary heart disease morbidity and
mortality, and also decreases the progression of
atherosclerosic lesions.28 In earlier studies, EEBC was
able to reduce the total – cholesterol and triglycerides
in streptozotocin – induced diabetic rats.8 The plant
extract has alkaloids, saponins, cardiac glycosides and
flavone glycosides.10,11 Saponins are glycosides of
steroids and are also triterpenes found in plants. They
bear a chemical similarity with cholesterol and may
either block the absorption of cholesterol or enhance
its excretion. Lipid peroxidation has been implicated
in the pathogenesis of  increased membrane rigidity,
reduced erythrocyte survival and perturbation in lipid
f luidity.29 The significant reduction in lipid
peroxidation (p<0.05) by 28.2% and 30.2% in
hypercholesterolemic rats treated with EEBC in this
study shows that EEBC is rich in antioxidant
compounds.
Conclusion
This study therefore suggests that B. coriacea seeds
contain potent antihypercholesterolemic agent which
either act synergestically or individually in ameliorating
hypercholesterolemia and its secondary complications.
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